期刊文献+

阎洪臣教授从喑痱论治运动神经元病经验 被引量:8

Experience of Professor Yan Hongchen in treating motor neuron disease from Yinpai
下载PDF
导出
摘要 阎洪臣教授是国家级名老中医,从医50余年,积累了丰富临床经验,尤善治疗疑难杂病。运动神经元病是一种原因不明的神经系统慢性进行性疾病,属世界医学疑难病之一,目前尚无有效防治手段,具有极高的致死率。阎教授致力于本病20余年,临证时着重强调要从《内经》?俳论治,以补肾开窍为法,地黄饮子为主方加减治疗,临床疗效显著,并附验案一则。 Professor Yan Hongchen is famous veteran teran doctors of traditional Chinese medicine, which has been engaged in medical work more than fifty years, and accumulated rich clinical experience, especially well at treating difficulty miscellaneous disease. Motor neuron disease is a kind of unexplained chronic progressive neurological disease, and is one of the world medical venereology. There is no effective prevention and control means, and it has a very high fatality rate. Professor Yan was devoted to the treatment of this disease for more than 20 years. In clinical practice, he emphasized the treatment should based on Yinpai in Neijing. Using resuscitation with invigorating kidney method and dihuang drink, the therapeutic effect is significant, and the following is a proven case.
出处 《中国中医药现代远程教育》 2015年第16期35-36,共2页 Chinese Medicine Modern Distance Education of China
基金 国家中医药管理局全国名老中医药专家阎洪臣传承工作室项目
关键词 喑痱 名医经验 运动神经元病 阎洪臣教授 痿证 Yinpai experience of famous doctor motor neuron disease Professor Yan Hongchen fistula syndrome
  • 相关文献

参考文献3

  • 1杨琼,樊东升.肌萎缩侧索硬化症临床诊断进展[J].中国现代神经疾病杂志,2012,12(3):245-251. 被引量:20
  • 2吴江,贾建平,崔丽英,等.神经病学[M].北京:人民卫生出版社,2012,7(2):314-315.
  • 3CheahB C,Vucic S,Krishnan A V,et al.Riluzole,neuroprotection andamy- otrophic lateral sclerosis[J].Current medicinal chemistry,2010,17(18):1942-1959.

二级参考文献68

  • 1Kiernan MC, Vucis S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet, 2011, 377:942-955.
  • 2Deng HX, Zhai H, Bigio EH, et aL FUS- immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol, 2010, 67:739- 748.
  • 3Beleza - Meireles A, Al - Chalabi A. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph Lateral Scler, 2009, 10:1-14.
  • 4Beghi E, Chio A, Couratier P, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler, 2011, 12:1-10.
  • 5Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta- analysis. J Neurol Neurosurg Psychiatry, 2011, 82:623-627.
  • 6Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry, 2010, 81:385-390.
  • 7Chio A, Mora G, Calvo A, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology, 2009, 72:725-731.
  • 8O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophie lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry, 2008, 79:30-32.
  • 9Kuzuhara S. Muro disease: amyotrophic lateral sclerosis/ parkinsonism- dementia complex in Kii Peninsula of Japan. Brain Nerve, 2011, 63:119-129.
  • 10Steele JC. Parkinsonism- dementia complex of Guam. Mov Disord, 2005, 20(Suppl 12):99-107.

共引文献45

同被引文献81

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部